Putative biomarkers of response to anti-PD-1 therapy in metastatic castration-resistant prostate cancer (mCRPC).

Khobe Chandran,Maria Dolores Fenor de la Maza,Jan Rekowski,Irene Shui,Bora Gurel,Pasquale Rescigno,Emily Cross,Suzanne Carreira,Wei Yuan,Ines Figueiredo,Ana Ferreira,Mateus Crespo,Susana Miranda,Claudia Bertan,Veronica Gil,Ruth Riisnaes,Razvan Cristescu,Charles Schloss,Christina Yap,Johann S. de Bono

Putative biomarkers of response to anti-PD-1 therapy in metastatic castration-resistant prostate cancer (mCRPC).

2021

155Background: Metastatic castration resistant prostate cancer (mCRPC) is a heterogeneous disease in which molecular stratification is needed to improve clinical outcomes. Targeting programmed cell...

Keywords:

Disease
Biomarker (medicine)
Prostate cancer
Oncology
castration resistant
anti pd 1
Medicine
Internal medicine
Cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations